Wu Yu-Ting, Chen Chung-Yu, Lai Wen-Ter, Kuo Chen-Chun, Huang Yaw-Bin
a School of Pharmacy, Master Program in Clinical Pharmacy, College of Pharmacy, Kaohsiung Medical University , Kaohsiung , Taiwan.
b Department of Administration, Cigu District Office , Taiwan , Taiwan.
Int J Neurosci. 2015;125(11):808-16. doi: 10.3109/00207454.2014.967351. Epub 2014 Oct 22.
Several studies have identified correlations between cancer and increased risks of ischemic stroke (IS), particularly following radiotherapy (RT) or chemotherapy (CT). However, data regarding relative risks of IS in oral cancer are limited. The aim of this study was to compare hazard ratios (HR) of IS among oral cancer patients treated with and without RT, CT, or both (CCRT).
We analyzed data collected by the Taiwan National Health Insurance Research Database (NHIRD) from 1996 to 2009, which covered approximately 99.5% of the medical claims submitted nationally. A total of 21,853 patients diagnosed with oral cancer from 2000 to 2008 were included. The Cox proportional hazard model was used to estimate the HRs of IS among different treatment modalities and a matched cohort.
The overall risk of IS was 1.24-fold greater in patients treated with RT/CT/CCRT than those treated with surgery alone and 1.08-fold greater for surgery with adjuvant therapy (radiotherapy or chemotherapy after surgery) after adjusting for confounding factors. The incidence of IS was 0.23-fold lower in matched control group than in the oral cancer cohort. In subgroup analysis, patients who received RT/CT/CCRT and aged <40 years old were at a 2.77-fold greater risk for IS than age-matched patients who underwent surgery alone, although this difference decreased with patient age.
Oral cancer patients, particularly those aged <40 years, who underwent RT or CT are at increased risks for IS. Other significant risk factors for IS included Charlson comorbidity index (CCI)>1, hypertension, coronary artery disease, and atrial fibrillation.
多项研究已确定癌症与缺血性卒中(IS)风险增加之间存在关联,尤其是在放疗(RT)或化疗(CT)之后。然而,关于口腔癌患者发生IS的相对风险的数据有限。本研究的目的是比较接受或未接受RT、CT或两者联合治疗(同步放化疗,CCRT)的口腔癌患者的缺血性卒中风险比(HR)。
我们分析了台湾国民健康保险研究数据库(NHIRD)在1996年至2009年收集的数据,这些数据涵盖了全国提交的约99.5%的医疗索赔。纳入了2000年至2008年期间共21853例诊断为口腔癌的患者。采用Cox比例风险模型来估计不同治疗方式以及匹配队列中IS的HR。
在调整混杂因素后,接受RT/CT/CCRT治疗的患者发生IS的总体风险比单纯接受手术治疗的患者高1.24倍,接受辅助治疗(手术后放疗或化疗)的患者发生IS的总体风险比单纯接受手术治疗的患者高1.08倍。匹配对照组中IS的发生率比口腔癌队列低0.23倍。在亚组分析中,接受RT/CT/CCRT治疗且年龄<40岁的患者发生IS的风险比年龄匹配的单纯接受手术治疗的患者高2.77倍,尽管这种差异随着患者年龄的增加而减小。
接受RT或CT治疗的口腔癌患者,尤其是年龄<40岁的患者,发生IS的风险增加。IS的其他重要风险因素包括Charlson合并症指数(CCI)>1、高血压、冠状动脉疾病和心房颤动。